<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02830633</url>
  </required_header>
  <id_info>
    <org_study_id>LNTME-01</org_study_id>
    <nct_id>NCT02830633</nct_id>
  </id_info>
  <brief_title>Trial to Evaluate Laparoscopy-assisted Nerve-preserved Total Mesorectal Excision (LNTME) Versus Open TME for Rectal Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Anhui Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Anhui Medical University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine: (1) whether laparoscopy-assisted nerve-preserved
      total mesorectal excision (LNTME) is as safe as open TME for rectal cancer, and (2) whether
      LNTME is more effective for protection of pelvic autonomic nerve function from surgical
      impairing when comparing to open TME.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative complications including bleeding, anastomotic leakage, postoperative infection, organ dysfunctions.</measure>
    <time_frame>postoperative 30 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The postoperative sexual function assessed by IIEF questionnaire</measure>
    <time_frame>postoperative one year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The postoperative voiding function assessed by IPSS questionnaire.</measure>
    <time_frame>postoperative one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>an expected average of 180 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative deaths</measure>
    <time_frame>postoperative 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The length postoperative hospital stay</measure>
    <time_frame>an expected average 8 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein</measure>
    <time_frame>postoperative 7 days</time_frame>
    <description>serum C-reactive protein level after operation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>LNTME</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopy-assisted nerve-preserved TME (LNTME) is conducted in rectal cancer patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OTME</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Open TME (OTME) is conducted in rectal cancer patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LNTME</intervention_name>
    <description>Patients in this group received laparoscopy-assisted nerve-preserved TME for treatment of rectal cancer</description>
    <arm_group_label>LNTME</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>OTME</intervention_name>
    <description>Patients in this group received traditional open TME for treatment of rectal cancer</description>
    <arm_group_label>OTME</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male patients

          2. From 18 years old to 60 years old

          3. Normal sexual function

          4. Tumor located in rectum (defined as 5- to 12-cm from the anal verge)

          5. Pathological confirmed rectal cancer

          6. Preoperative T stage ranging from T1 to T4a according to the 7th Edition of AJCC
             Cancer Staging Manual

          7. Tumor size &lt; 5 cm

          8. ASA score was I-II

          9. Informed consent was written

        Exclusion Criteria:

          1. Distant cancer metastasis

          2. History of abdominal surgery

          3. With other type of malignancy

          4. Preoperative voiding dysfunction

          5. Preoperative sexual dysfunction

          6. Refusing to attend this trial
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Han-Hui HH YAO, M.D.</last_name>
    <phone>+86-18956087855</phone>
    <email>ruoyubaba@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Liu L LIU, PhD</last_name>
    <phone>+86-15056017712</phone>
    <email>liuwkjy@126.com</email>
  </overall_contact_backup>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2016</study_first_submitted>
  <study_first_submitted_qc>July 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2016</study_first_posted>
  <last_update_submitted>July 9, 2016</last_update_submitted>
  <last_update_submitted_qc>July 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Anhui Medical University</investigator_affiliation>
    <investigator_full_name>Han-Hui YAO</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>laparoscopy</keyword>
  <keyword>rectal cancer</keyword>
  <keyword>pelvic autonomic nerve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

